Researchers Identified CIRBP as Tumor Suppressor
A new study reveals that CIRBP protein expression inhibits cell proliferation in multiple myeloma.
Updated on Sept. 22, 2026 in Cancer
Scientists have identified the protein CIRBP as a key tumor suppressor in multiple myeloma. The study found that CIRBP levels are typically decreased in patients, while its overexpression inhibits cancer cell viability and reduces tumor burden.
Why it matters
Understanding the regulatory mechanisms of CIRBP provides new insight into how multiple myeloma cells interact with the immune system. By mapping this pathway, researchers have uncovered a potential target for modulating macrophage activation in cancer treatment.
Researchers observed that CIRBP binds to intron1 of PKM2 pre-mRNA to promote nonsense-mediated decay and suppress macrophage chemotaxis. The study confirms that elevated PKM2 levels effectively reverse the suppression of these immune processes.
The players
Nature Communications
This is a peer-reviewed, open-access scientific journal that publishes high-quality research from all areas of the natural sciences.
The details
The research demonstrates that CIRBP overexpression suppresses multiple myeloma cell proliferation and reduces tumor burden in xenograft models. Furthermore, CIRBP-expressing cells inhibit macrophage alternative activation by downregulating PKM2 levels.
Timeline
September 22, 2026: The research findings were formally published.
The Big Picture
This discovery marks a shift in the study of the PKM2 metabolic pathway in oncology by demonstrating how CIRBP-mediated splicing regulation influences cancer cell viability. The findings bridge gaps between post-transcriptional regulation and immune cell behavior in the cancer microenvironment.
While these findings currently apply to preclinical models, they offer a foundation for developing future targeted therapies that modulate immune responses in myeloma patients. Patients should consult with oncologists regarding established treatment protocols as these laboratory results continue to evolve.
The takeaway
This study highlights the critical role of RNA-binding proteins in suppressing cancer progression through metabolic regulation. Future research into these pathways could lead to improved strategies for controlling tumor growth and immune modulation.
Further reading
For more information on current developments in oncology, visit our Cancer section.
More information
Review the full findings in the peer-reviewed research article.
Source note: This article includes information reported by Nature.
